Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalytic Asymmetric Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109628504A details a biphasic microbial resolution method. This technology enhances purity and yield for pharmaceutical intermediates while offering supply chain cost advantages.
Patent CN101302543A reveals a microbial method for high-purity (S)-phenylethylene glycol. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.